At the time of our study, around the turn of the millennium, published reports indicated that TP53-mutations were frequent in OSCC (around 35%) and it had been noted that expression of TP53 was not an indicator of TP53-mutation in these cancers [9,10,11]. The gene discussed is TP53; the disease is cancer.